Severe Adverse Events
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer (NCT05310305) | Lei Li | 2022-03-26 |
| Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study. (NCT04479553) | Zhong Wang | 2020-08-17 |
| Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study (NCT02239237) | Zhong Wang | 2014-09-01 |
Track Severe Adverse Events automatically
Every clearance here is in the API, with alerts when new ones post.